Patents by Inventor Lyle L. Moldawer

Lyle L. Moldawer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating or preventing ischemia-reperfusion injury
    Patent number: 6086868
    Abstract: There is disclosed a method of treating ischemia-reperfusion injury comprising administering an effective amount of Interleukin-10 to a patient suffering or expected to suffer from such injury.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: July 11, 2000
    Assignee: Schering Corporation
    Inventors: Lyle L. Moldawer, James M. Seeger, Timothy R. S. Harward, Satwant K. Narula
  • Parenteral nutrition with medium and long chain triglycerides
    Patent number: 4703062
    Abstract: Medium chain triglyceride containing lipid emulsions for the nutrition of liver diseased or septicemic patients are improved by the inclusion in the emulsions of long chain triglycerides. The emulsions may also contain amino acids in proportions desirable for the nutrition of liver diseased patients, as well as carbohydrates, drugs, vitamins and electrolytes.
    Type: Grant
    Filed: September 9, 1985
    Date of Patent: October 27, 1987
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: George L. Blackburn, Vigen K. Babayan, Bruce Bistrian, Lyle L. Moldawer, Richard Cotter
  • Treatment of protein malnourished bacterially infected humans with LEM
    Patent number: 4542017
    Abstract: Exogenous LEM (Leukocyte Endogenous Mediator, also referred to as endogenous pyrogen) is parenterally administered to humans who are protein malnourished and are infected with bacteria, in order to preinitiate and then maintain the normal metabolic responses to the tissue damage occurring during infection, and thereby promote the normal metabolic response by the human.
    Type: Grant
    Filed: December 9, 1982
    Date of Patent: September 17, 1985
    Inventors: Lyle L. Moldawer, George L. Blackburn, Bruce R. Bistrian
  • Treatment of protein malnourished surgical patients
    Patent number: 4512974
    Abstract: Exogenous LEM (Leukocyte Endogenous Mediator, also referred to as endogenous pyrogen) is parenterally administered to humans who are protein malnourished and are to undergo surgery, in order to preinitiate and then maintain the normal metabolic responses to the tissue damage occurring during surgery, and thereby promote the normal metabolic response by the human (patient).
    Type: Grant
    Filed: December 8, 1982
    Date of Patent: April 23, 1985
    Inventors: Lyle L. Moldawer, George L. Blackburn, Bruce R. Bistrian